Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Study findings from University of Lodz provide new insights into vaccines
March 12th, 2008
Fresh data on vaccines are presented in the report 'Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis.' "Toxoplasma gondii is responsible for fetopathy in farm animals and humans and severe disease in immunocompromised individuals (i.e. AIDS patients). Effective vaccines, inducing protective and long-lasting immunity to this global parasite, are still desired," investigators in Lodz, Poland report. "In the work, we evaluated the immunogenic and immunoprotective activity of Escherichia coli chimeric Dr fimbriae bearing selected antigenic epitopes of three T. gondii antigens (SAG1, GRA1 and MAG1), in comparison with...
Source: Vaccine Weekly (2008-03-12)
|
